What This Cytokinetics Insider Sale Might Mean With the Stock Up 110%
Blum exercised options at $10.60 per share and immediately sold them at $82.02, capturing gains from a 122% stock surge over the past year. He retains 381,986 shares and maintains a 0.31% ownership…
Read the full articleYou might also wanna read
FMR LLC Reduces Stake in Cytokinetics Inc: A Detailed Analysis
Ron Baron Stock Picks Related Stocks: CYTK , AAPL , AMZN , GOOGL , MSFT , NVDA
Autonomix Medical Enters into $2.6 Million Warrant Inducement Priced At-the-Market Under Nasdaq Rules
THE WOODLANDS, TX, July 13, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) ("Autonomix” or the "Company”), a medical device
Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif., July 14, 2026 (GLOBE NEWSWIRE) -- Tenaya Therapeutics Inc. (NASDAQ: TNYA), a clinical-stage biotechnology compa
Biotech NRx to sell new shares to fund growth and operations
#NRXP NRx Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
Insider Sell: Santos da Silva Jorge Sells 102,225 Shares of MoonLake Immunotherapeutics (MLTX)
Related Stocks: MLTX
Attovia Therapeutics files for Nasdaq IPO to fund immune-disease biologics
Tao Fu's San Carlos biotech is seeking an ATTO listing before disclosing price range, share count or valuation.
Comments
Sign in to join the conversation.
No comments yet. Be the first.